Navigation Links
Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting
Date:6/2/2008

Monogram announces availability of HERmark and HER1 and HER3 Total Protein

Assays in Collaborative Biomarker Study

SOUTH SAN FRANCISCO, Calif., June 2 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced that scientific collaborators have presented additional clinical results on HERmark(TM), the company's novel oncology assay, as a means to measure HER2 total protein and homodimer levels and predict response to Herceptin(R) (trastuzumab) in patients with metastatic breast cancer at the 44th ASCO Annual Meeting taking place in Chicago, Illinois. Monogram also announced the initiation of a Collaborative Biomarker Study involving the company's HERmark Breast Cancer Assay and the HER1 and HER3 Total Protein Assays.

"HERmark is the first diagnostic built upon our VeraTag technology," said Monogram CEO Bill Young. "Today we are announcing two developments that will elevate the profile of HERmark in the oncology community. First, important clinical data presented today demonstrates the superiority of HERmark over FISH testing for HER2. Second, we are initiating a study that will provide an opportunity for participating oncologists to experience first hand the superiority of HERmark in their clinical practices. We look forward to completing our commercial planning and to a future commercial launch of HERmark throughout the U.S."

HERmark Clinical Data

The oral presentation, entitled "Total HER2 and HER2 Homodimer Levels Predict Response to trastuzumab," discussed the findings of a study that investigated the HERmark assay's ability to identify and discriminate among patients with metastatic breast cancer who experienced different degrees of response to trastuzumab. The stu
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting
2. Monogram Biosciences Announces First Quarter 2008 Financial Results Conference Call
3. Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference
4. Raven biotechnologies Announces Collaboration With Monogram Biosciences to Advance Diagnostic Cancer Technologies
5. Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program
6. Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology
7. Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts
8. Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
9. Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call
10. Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference
11. Monogram Announces Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 The new ... Spain , available today on PharmaBoardroom.com for ... Eurozone crisis that rocked the Spanish economy in 2009, and ... pharma community has remained pragmatic in times of trouble. ... still the fifth biggest European market, and the general conditions ...
(Date:9/18/2014)... A novel robotic system that can operate ... being tested as part of a biomedical research partnership ... the aim of determining if the robot, in conjunction ... faster, more accurate, less costly, and less discomforting for ... to deliver prostate cancer therapies with greater precision. , ...
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... "Global and Chinese Stem Cell Industry Report, 2014-2017" ... are undifferentiated biological cells that can differentiate into specialized ... stem cells. Stem cell therapy can be applied to ... system disease), nervous system diseases, damage or lesion of ...
(Date:9/18/2014)... 2014  U.S. biotech company Kultevat has ... for technology developed by the Donald Danforth Plant ... including for applications in production of natural rubber in ... was developed under the direction of Roger Beachy ... president of the Danforth Plant Science Center, and is ...
Breaking Biology Technology:PharmaBoardroom Releases New Spain Pharmaceuticals Report 2PharmaBoardroom Releases New Spain Pharmaceuticals Report 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 4Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 5Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 6Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Kultevat obtains license of gene switch technology 2
... Israel, Jan. 31, 2012   InspireMD, Inc. (OTC BB: ... company focusing on the development and commercialization of ... patients with Acute Myocardial Infarctions, today announced the ... of Directors as an independent director.  Dr. Barry ...
... of the wonders of the science world, with the potential ... next generation of aircraft. The new finding at the University ... graphene can also be used for distilling alcohol. In ... by Professor Sir Andre Geim shows that graphene-based membranes are ...
... on previous research in which microbubbles were used to improve ... which can be processed to create a useful biofuel. Biofuels, ... fossil fuels and algae, in particular, has the potential to ... has been no cost-effective method of harvesting and removing the ...
Cached Biology Technology:InspireMD Appoints Dr. James Barry to Its Board of Directors 2InspireMD Appoints Dr. James Barry to Its Board of Directors 3InspireMD Appoints Dr. James Barry to Its Board of Directors 4Supermaterial goes superpermeable 2Microbubbles provide new boost for biofuel production 2
(Date:9/18/2014)... Worcester, Mass. A novel robotic system that can ... currently being tested as part of a biomedical research ... with the aim of determining if the robot, in ... biopsies faster, more accurate, less costly, and less discomforting ... potential to deliver prostate cancer therapies with greater precision. ...
(Date:9/18/2014)... that prompts millions of Americans to undertake jaunts into the ... a little longer within a century, according to new research. ... areas of the United States as summer temperatures linger later ... Global Ecology and Biogeography . For instance, the paper ... tree of New Hampshire could change color one to ...
(Date:9/18/2014)... Sept. 18, 2014 -- Arizona turned its newborn screening program ... few short months, earning it the first-ever Newborn Screening Quality ... of Dimes presented Will Humble, M.P.H., Arizona,s Department of Health ... today. Mr. Humble established a policy of full transparency for ... newborn blood samples to the lab for analysis, and set ...
Breaking Biology News(10 mins):Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4March of Dimes honors Arizona with first-ever newborn screening award 2March of Dimes honors Arizona with first-ever newborn screening award 3
... genome of a marine bacterium living 2,500 meters below ... adapts in extreme thermal and chemical gradients, according to ... PLoS Genetics , an open-access publication published by the ... the bacterium Nautilia profundicola , a microbe that ...
... in Arizona,s Santa Catalina Mountains as summer temperatures rise, ... in Tucson. The flowering ranges of 93 plant ... where the same species flowered the previous ten years. ... region increased about 1.8 degree Fahrenheit (1 degree C.). ...
... wondered how melanoma cells travel from primary tumors on the ... they become more aggressive, resistant to therapy, and deadly. Now, ... short strand of RNA called microRNA (miRNA) that is over-expressed in ... ...
Cached Biology News:Genetic adaptations key to microbe's survival in challenging environment 2Plants take a hike as temperatures rise 2Plants take a hike as temperatures rise 3NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis 2NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis 3
Request Info...
Agarose-LE, 250 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: